PlumX Metrics
Embed PlumX Metrics

Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency

Journal of Medicinal Chemistry, ISSN: 0022-2623, Vol: 42, Issue: 10, Page: 1767-1777
1999
  • 17
    Citations
  • 0
    Usage
  • 8
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

Article Description

The anti-HIV agent cosalane inhibits both the binding of gp120 to CD4 as well as an undefined postattachment event prior to reverse transcription. Several cosalane analogues having an extended polyanionic 'pharmacophore' were designed based on a hypothetical model of the binding of cosalane to CD4. The analogues were synthesized, and a number of them displayed anti-HIV activity. One of the new analogues was found to possess enhanced potency as an anti-HIV agent relative to cosalane itself. Although the new analogues inhibited both HIV-1 and HIV-2, they were more potent as inhibitors of HIV-1 than HIV-2. Mechanism of action studies indicated that the most potent of the new analogues inhibited fusion of the viral envelope with the cell membrane at lower concentrations than it inhibited attachment, suggesting inhibition of fusion as the primary mechanism of action.

Bibliographic Details

Mark Cushman; Shabana Insaf; Gitendra Paul; Jeffrey A. Ruell; Erik De Clercq; Dominique Schols; Christophe Pannecouque; Myriam Witvrouw; Catherine A. Schaeffer; Jim A. Turpin; Karen Williamson; William G. Rice

American Chemical Society (ACS)

Biochemistry, Genetics and Molecular Biology; Pharmacology, Toxicology and Pharmaceutics

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know